IBX 0.00% 7.0¢ imagion biosystems limited

Ann: Imagion Biosystems December 2021 Investor Newsletter, page-31

  1. 2,889 Posts.
    lightbulb Created with Sketch. 241
    Aren’t they employed to estimate accurately? Who is accountable?
    Ok on Covid, but we were already living with covid when we started the trials, any sort of planning would have identified this as a risk and controls should have been put in place. Who is responsible for being overly ambitious? What other reasons are there that you are alluding to.
    Lets not muddy the waters, management has failed us and the share price is reflecting that outcome. I’ll reiterate again, that trials were meant to be finished 9 months after starting which is September 2021. We were then advised end of this year to finish. We are at the end of the year and all we are receiving is vague timelines. This is on management and no one else.
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.